Botanical species · safety record

Cota tinctoria

The EFSA Compendium of Botanicals holds 7 constituent measurements for Cota tinctoria. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Cota tinctoria (L.) J.Gay

7Constituent measurements
0Safety records
6Cited sources
0Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Camphor2
  • 1,8-cineole1
  • Alkaloids1
  • Labdane diterpenes1
  • Polyacetylene derivatives1
  • Saponins1

Plant parts

  • Aerial part of plants2
  • Flower2
  • Live plants1
  • Roots and other underground parts1
  • Unspecified1

Preparations

  • Essential oil3
  • Solvent extraction3

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
1,8-cineoleFlowerEssential oil7.9 PercentGaschromatography (GC)No resolvable identifier
AlkaloidsLive plantsSolvent extractionGC-MSNo resolvable identifier
CamphorAerial part of plantsEssential oil≤ 9.3 PercentGC-MSNo resolvable identifier
CamphorAerial part of plantsEssential oil≥ 1.8 PercentGC-MSNo resolvable identifier
Labdane diterpenesFlowerSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier
Polyacetylene derivativesRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier
SaponinsUnspecifiedNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Vaverkova, Stefania., Holla, Magdalena., Mikulasova, Maria., Haban, Miroslav., Otepka, Pavol., Vozar, Igor., Salamon, I. Qualitative properties and content of essential oil in the flowerheads of Anthemis tinctoria L. . Proceedings of the first international symposium on chamomile research, development and production, 2007, no. 749, p. 283-+.
  2. Mogosan, Cristina., Hanganu, Daniela., Aciu, Mariana., Muresan, Liana. Evaluation of diuretic, saluretic and uricosuric actions of the tinctures and saponins from Anthemis tinctoria L. (Asteraceae) and Pulmonaria officinalis L. (Boraginaceae). Farmacia (bucharest, romania), 2002, vol. 50, no. 3, p. 28-34.
  3. Bohlmann, Ferdinand., Arndt, Christian., Bornowski, Hans., Kleine, Kaethe Marie. Polyacetylene compounds. XLVIII. The polyynes of the genus Anthemis. Chemische berichte, 1963, vol. 96, p. 1485-94.
  4. Bittencourt, Nilza de Lucas Rodrigues., Ueda-Nakamura, Tania., Dias Filho, Benedito Prado., Nakamura, Celso Vataru. Antitrypanosoma activity of a semi-purified subfraction rich in labdane sesquiterpenes, obtained from flowers of Anthemis tinctoria, against Trypanosoma cruzi. Pharmacology & pharmacy, 2011, vol. 2, no. 2, p. 47-55.
  5. Pavlovic, Milica., Lakusic, Dmitar., Kovacevic, Nada., Tzakou, Olga., Couladis, Maria. Comparative Analysis of Essential Oils of Six Anthemis Taxa from Serbia and Montenegro . Chemistry & biodiversity, 2010, vol. 7, no. 5, p. 1231-1244.
  6. Hultin, E., Torssell, K. Alkaloid-screening of swedish plants. Phytochemistry, 1965, vol. 4, no. 3, p. 425-433.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue